BranchLab, a NYC-based data science company developing advanced AI software that enables healthcare brands to reach the right consumers, raised an undisclosed amount in Seed funding.
The round led by newark venture partners with participation from Aperiam.
The company intends to use the funds to accelerate product development and market expansion for its privacy-safe healthcare advertising solutions for TV.
Founded by Josh Walsh, CEO, Michael Parkes, President and CRO, and Chris Cagle, CTO, BranchLab is a data science company developing advanced AI software, enabling healthcare brands to reach the right consumers while guaranteeing privacy. BranchLab’s database, HealthGraph™, aggregates anonymized data from over 300 million US residents and their healthcare journeys, including data on 2.1 million healthcare providers. Built atop a secure cleanroom environment, HealthGraph™ is updated weekly with various healthcare data points, ensuring its comprehensiveness and relevance. Leveraging this data asset, BranchLab applies machine learning to create comprehensive audience models from the underlying anonymized data. These models incorporate billions of data points to assign value to media across TV environments enabling targeted advertising, as well as in-flight campaign optimization.
It operates in the U.S. and it has offices in Colorado and Pennsylvania.
FinSMEs
07/06/2024